ArticleBioData mining2026
An online non-radiographic osteoporosis prediction calculator constructed using interpretable machine learning.
Article in BioData mining, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOsteoporosis represents a major health challenge in aging populations, yet its diagnosis largely depends on dual-energy X-ray absorptiometry (DXA), which is both costly and radiation-based. This study aimed to develop a practical, non-radiographic prediction model for osteoporosis using interpretable machine learning techniques and to implement it as an accessible online calculator for rapid clinical and community screening.
methodsData were derived from the 2008–2011 waves of the Korean National Health and Nutrition Examination Survey (KNHANES). Individuals with over 30% missing data were excluded, and incomplete variables were imputed via polynomial interpolation (for continuous variables) and mode imputation (for categorical variables). After performing Spearman correlation analysis (p < 0.001) to identify osteoporosis-related features, GradientBoost-RFE and LASSO regression were applied for dimensionality reduction, yielding 15 essential predictors, including age, sex, body mass index (BMI), etc. GradientBoost, CatBoost, and XGBoost algorithms were trained to estimate abnormal DXA results and classify bone status. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), specificity (SPE), and accuracy (ACC), with a temporal validation set (the 2008 wave of KNHANES) for testing.
resultsA total of 18,179 participants were included, with 14,747 in the development cohort and 3,432 in the temporal validation set. Among them, 64.6% exhibited normal DXA results. The optimal model achieved an AUC of 0.845 and SPE of 0.897 for identifying abnormal DXA outcomes, and demonstrated an AUC of 0.876 and SPE of 0.909 in temporal validation. For multiclass classification (normal, osteopenia, osteoporosis), the model reached ACC of 0.724 and 0.744, and SPE of 0.803 and 0.819 in the development and validation datasets, respectively.
conclusionWe developed and validated an interpretable machine learning model that accurately predicts osteoporosis risk and DXA abnormalities using readily available demographic, biochemical, and lifestyle data. To facilitate clinical translation, the model has been deployed as an interactive online calculator, enabling non-invasive, rapid osteoporosis risk assessment without radiological testing. This tool may support early identification of high-risk individuals, optimize DXA utilization, and enhance preventive care strategies across diverse healthcare settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.